About NovaPharm
A pharmaceutical company designed around evidence, optionality and accountable growth.
NovaPharm exists to connect qualified supply, regulatory intelligence, quality governance and useful technology around the needs of UK B2B healthcare.
Why NovaPharm
The supply problem is operational, not only commercial.
Specialty pharmaceutical supply can become fragmented across product rights, regulatory pathways, supplier evidence, warehouse systems and customer processes. NovaPharm's model is designed to make those dependencies visible and govern them together.
The company is preparing a three-pillar sourcing strategy, a capital-efficient third-party logistics model and a digital B2B operating platform. Those capabilities remain staged: strategy, preparation and roadmap are not presented as licences, inventory or achieved NHS supply.
Operating discipline
Build the evidence trail before building the volume.
NovaPharm's model connects product identity, supplier evidence, quality status, documents, orders and fulfilment events around one governed record.
Operating principles
What must remain true as NovaPharm develops.
Evidence before claims
Quality across every partner
One source of operational truth
Human accountability for technology
Transparent capability maturity
Company structure
Explore the organisation behind the strategy.
Start a qualified conversation